Rationale and parameters for medication-free research in psychosis.
作者信息
McGlashan Thomas H
出版信息
Schizophr Bull. 2006 Apr;32(2):300-2. doi: 10.1093/schbul/sbj045. Epub 2006 Feb 3.
Abstract
摘要
相似文献
1
Rationale and parameters for medication-free research in psychosis.精神病无药治疗研究的基本原理和参数
Schizophr Bull. 2006 Apr;32(2):300-2. doi: 10.1093/schbul/sbj045. Epub 2006 Feb 3.
2
Medication discontinuation in first episode psychosis: thinking about the offset of psychotic disorders.首发精神病的药物停用：关于精神障碍缓解的思考
Aust N Z J Psychiatry. 2018 Sep;52(9):819-821. doi: 10.1177/0004867418790087. Epub 2018 Jul 30.
3
Clozapine: acquittal of the usual suspect.氯氮平：无罪的“惯犯”。
World J Biol Psychiatry. 2009;10(4 Pt 3):981-4. doi: 10.1080/15622970903186229.
4
Antipsychotic drugs: when and how to withdraw them?
Psychother Psychosom. 2006;75(3):133-8. doi: 10.1159/000091770.
5
Examining the effectiveness of antipsychotic medication in first-episode psychosis.检查抗精神病药物在首发精神病中的疗效。
J Psychopharmacol. 2012 May;26(5 Suppl):27-32. doi: 10.1177/0269881112439252. Epub 2012 Feb 15.
6
Prescription of antipsychotic medication to patients at ultra high risk of developing psychosis.向有超高风险发展为精神病的患者开具抗精神病药物处方。
Int Clin Psychopharmacol. 2009 Jul;24(4):223-8. doi: 10.1097/YIC.0b013e32832e0a76.
7
Psychosis and antipsychotic medications in Alzheimer's disease: clinical management and research perspectives.阿尔茨海默病中的精神病症状与抗精神病药物：临床管理与研究视角
Dement Geriatr Cogn Disord. 2004;17(1-2):78-90. doi: 10.1159/000074279. Epub 2003 Oct 17.
8
[Use of methadone in the treatment of psychotic patients with heroin dependence].美沙酮在治疗海洛因依赖精神病患者中的应用
Tidsskr Nor Laegeforen. 2000 Jan 20;120(2):195-8.
9
Introduction. Antipsychotic agents: clinical, economic, and legal considerations in the treatment of psychosis.引言。抗精神病药物：精神病治疗中的临床、经济和法律考量
J Clin Psychiatry. 1999;60 Suppl 19:3-4.
10
Challenges in the management of early psychosis.早期精神病管理中的挑战。
J Psychopharmacol. 2012 May;26(5 Suppl):6-7. doi: 10.1177/0269881111405365.
引用本文的文献
1
Weighing the evidence for harm from long-term treatment with antipsychotic medications: A systematic review.权衡抗精神病药物长期治疗的危害证据：一项系统综述。
Am J Orthopsychiatry. 2016;86(5):477-85. doi: 10.1037/ort0000106. Epub 2015 Dec 14.
2
The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics.在病情稳定的精神分裂症患者中使用持续治疗与安慰剂或间歇治疗策略：对使用第一代和第二代抗精神病药物的随机对照试验的系统评价和荟萃分析
CNS Drugs. 2015 Aug;29(8):637-58. doi: 10.1007/s40263-015-0269-4.
3
Antipsychotic Maintenance Treatment: Time to Rethink?抗精神病药物维持治疗：是时候重新思考了？
PLoS Med. 2015 Aug 4;12(8):e1001861. doi: 10.1371/journal.pmed.1001861. eCollection 2015 Aug.
本文引用的文献
1
From dopamine to salience to psychosis--linking biology, pharmacology and phenomenology of psychosis.从多巴胺到显著性再到精神病——连接精神病的生物学、药理学和现象学
Schizophr Res. 2005 Nov 1;79(1):59-68. doi: 10.1016/j.schres.2005.01.003.
2
Subjective well-being under the neuroleptic treatment and its relevance for compliance.
Acta Psychiatr Scand Suppl. 2005(427):29-34. doi: 10.1111/j.1600-0447.2005.00542.x.
3
Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up.精神分裂症患者神经认知和阴性症状对功能结局的预测价值：一项长达7年随访的首发纵向研究
Am J Psychiatry. 2005 Mar;162(3):495-506. doi: 10.1176/appi.ajp.162.3.495.
4
Half a century of antipsychotics and still a central role for dopamine D2 receptors.半个世纪的抗精神病药物发展历程，多巴胺D2受体仍占据核心地位。
Prog Neuropsychopharmacol Biol Psychiatry. 2003 Oct;27(7):1081-90. doi: 10.1016/j.pnpbp.2003.09.004.
5
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design.奥氮平与安慰剂治疗有精神病前驱症状风险患者的北美PRIME随机双盲临床试验。I. 研究原理与设计。
Schizophr Res. 2003 May 1;61(1):7-18. doi: 10.1016/s0920-9964(02)00439-5.
6
Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms.旨在降低具有阈下症状的临床样本中首次发作精神病进展风险的干预措施的随机对照试验。
Arch Gen Psychiatry. 2002 Oct;59(10):921-8. doi: 10.1001/archpsyc.59.10.921.
7
Personal evaluation of transitions in treatment (PETiT):a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia.治疗转变的个人评估（PETiT）：一种测量精神分裂症抗精神病药物治疗主观方面的量表。
Schizophr Res. 2002 Jul 1;56(1-2):37-46. doi: 10.1016/s0920-9964(01)00161-x.
8
Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity.基于前驱症状结构化访谈对精神分裂症初始前驱期的前瞻性诊断：评分者间信度和预测效度的初步证据。
Am J Psychiatry. 2002 May;159(5):863-5. doi: 10.1176/appi.ajp.159.5.863.
9
Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia.
Am J Psychiatry. 2001 Nov;158(11):1835-42. doi: 10.1176/appi.ajp.158.11.1835.
10
Zotero 插件